NCT05440071View on ClinicalTrials.gov

PoSt-market Assessment on Safety and Performance of J-sHAPed xFINE Lead

UnknownOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

September 30, 2024

Conditions
Bradycardia
Interventions
DEVICE

JX- XFINE lead

Pacemaker subjects implanted with one JX - XFINE passive pacing lead

Sponsors

Lead Sponsor

MicroPort CRM
All Listed Sponsors
lead

MicroPort CRM

INDUSTRY

NCT05440071 - PoSt-market Assessment on Safety and Performance of J-sHAPed xFINE Lead | Biotech Hunter | Biotech Hunter